female scientist inspecting beaker

Research & Guidelines

ASCO advances clinical research through scientific meetings, educational programs, and peer-reviewed journals designed to help translate research results into quality care.

  • New Telehealth in Oncology Standards

    ASCO has issued a new set of practice standards: Telehealth in Oncology. These standards provide general guidance on implementing telehealth across general and specialty settings in the oncology field.

    Learn More
  • Newly Updated HER2-Negative Metastatic Breast Cancer Guideline

    The guideline, "Chemo- and Targeted Therapy for Patients with HER2-Negative Metastatic Breast Cancer" is now available. Recommendations include immune checkpoint inhibitor may be added to chemotherapy as first-line therapy for patients with metastatic triple-negative breast cancer positive for PD-L1.

    Read More

Random Quote

"I value the broad exposure ASCO affords my specialty throughout the oncology world. All of us have the opportunity to learn about the latest advances in our field and to broadly share our own research."
Clifford Hudis, MD, FASCO
ASCO CEO